183 related articles for article (PubMed ID: 31101130)
1. The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia.
Musolino V; Gliozzi M; Nucera S; Carresi C; Maiuolo J; Mollace R; Paone S; Bosco F; Scarano F; Scicchitano M; Ruga S; Zito MC; Colica C; Macrì R; Palma E; Ragusa S; Muscoli C; Mollace V
Lipids Health Dis; 2019 May; 18(1):115. PubMed ID: 31101130
[TBL] [Abstract][Full Text] [Related]
2. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.
Gliozzi M; Walker R; Muscoli S; Vitale C; Gratteri S; Carresi C; Musolino V; Russo V; Janda E; Ragusa S; Aloe A; Palma E; Muscoli C; Romeo F; Mollace V
Int J Cardiol; 2013 Dec; 170(2):140-5. PubMed ID: 24239156
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study.
Mollace V; Scicchitano M; Paone S; Casale F; Calandruccio C; Gliozzi M; Musolino V; Carresi C; Maiuolo J; Nucera S; Riva A; Allegrini P; Ronchi M; Petrangolini G; Bombardelli E
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):136-143. PubMed ID: 30501605
[TBL] [Abstract][Full Text] [Related]
4. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome.
Parafati M; Lascala A; Morittu VM; Trimboli F; Rizzuto A; Brunelli E; Coscarelli F; Costa N; Britti D; Ehrlich J; Isidoro C; Mollace V; Janda E
J Nutr Biochem; 2015 Sep; 26(9):938-48. PubMed ID: 26025327
[TBL] [Abstract][Full Text] [Related]
5. Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study.
Bruno A; Pandolfo G; Crucitti M; Maisano A; Zoccali RA; Muscatello MRA
J Nutr Biochem; 2017 Feb; 40():32-35. PubMed ID: 27846426
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering effect of bergamot polyphenolic fraction: role of pancreatic cholesterol ester hydrolase.
Musolino V; Gliozzi M; Carresi C; Maiuolo J; Mollace R; Bosco F; Scarano F; Scicchitano M; Maretta A; Palma E; Iannone M; Morittu VM; Gratteri S; Muscoli C; Fini M; Mollace V
J Biol Regul Homeost Agents; 2017; 31(4):1087-1093. PubMed ID: 29254319
[TBL] [Abstract][Full Text] [Related]
7. Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kit
Carresi C; Musolino V; Gliozzi M; Maiuolo J; Mollace R; Nucera S; Maretta A; Sergi D; Muscoli S; Gratteri S; Palma E; Bosco F; Giancotta C; Muscoli C; Marino F; Aquila I; Torella D; Romeo F; Mollace V
J Mol Cell Cardiol; 2018 Jun; 119():10-18. PubMed ID: 29654879
[TBL] [Abstract][Full Text] [Related]
8. Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
Parafati M; Lascala A; La Russa D; Mignogna C; Trimboli F; Morittu VM; Riillo C; Macirella R; Mollace V; Brunelli E; Janda E
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30388763
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effect of Bergamot Polyphenolic Fraction and Red Yeast Rice Extract in Rats Fed a Hyperlipidemic Diet: Role of Antioxidant Properties and PCSK9 Expression.
Mollace R; Macrì R; Tavernese A; Gliozzi M; Musolino V; Carresi C; Maiuolo J; Fini M; Volterrani M; Mollace V
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276836
[TBL] [Abstract][Full Text] [Related]
10. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies.
Mollace V; Sacco I; Janda E; Malara C; Ventrice D; Colica C; Visalli V; Muscoli S; Ragusa S; Muscoli C; Rotiroti D; Romeo F
Fitoterapia; 2011 Apr; 82(3):309-16. PubMed ID: 21056640
[TBL] [Abstract][Full Text] [Related]
11. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
12. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
13. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of Bergamot Polyphenolic Fraction on reno-cardiac damage induced by DOCA-salt and unilateral renal artery ligation in rats.
Carresi C; Cardamone A; Coppoletta AR; Caminiti R; Macrì R; Lorenzo F; Scarano F; Mollace R; Guarnieri L; Ruga S; Nucera S; Musolino V; Gliozzi M; Palma E; Muscoli C; Volterrani M; Mollace V
Biomed Pharmacother; 2024 Feb; 171():116082. PubMed ID: 38242036
[TBL] [Abstract][Full Text] [Related]
15. [Effects of pure total flavonoids from Citrus changshan-huyou on blood lipid metabolism in hyperlipidemic rats].
Yang PL; Jiang JP; Li QQ; Wu XM; Chen ZY
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):936-943. PubMed ID: 28994538
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia.
Napoli C; Leccese M; Palumbo G; de Nigris F; Chiariello P; Zuliani P; Somma P; Di Loreto M; De Matteis C; Cacciatore F; Abete P; Liguori A; Chiariello M; D'Armiento FP
Coron Artery Dis; 1998; 9(5):257-64. PubMed ID: 9710685
[TBL] [Abstract][Full Text] [Related]
17. Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.
Musolino V; Gliozzi M; Scarano F; Bosco F; Scicchitano M; Nucera S; Carresi C; Ruga S; Zito MC; Maiuolo J; Macrì R; Amodio N; Juli G; Tassone P; Mollace R; Caffrey R; Marioneaux J; Walker R; Ehrlich J; Palma E; Muscoli C; Bedossa P; Salvemini D; Mollace V; Sanyal AJ
Sci Rep; 2020 Feb; 10(1):2565. PubMed ID: 32054943
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
19. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
